InterviewSolution
Saved Bookmarks
| 1. |
The National Task Force on COVID-19 recently decided against using which drug in clinical management protocols? |
| Answer» The National Task Force on COVID-19 recently decided against using Itolizumab in clinical management protocols. The Drugs Controller General of India (DCGI) had earlier approved for "restricted emergency use" of the drug. | |